Hajduk Philip J, Mack Jamey C, Olejniczak Edward T, Park Chang, Dandliker Peter J, Beutel Bruce A
Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, Illinois 60064, USA.
J Am Chem Soc. 2004 Mar 3;126(8):2390-8. doi: 10.1021/ja039480v.
An NMR-based alternative to traditional X-ray crystallography and NMR methods for structure-based drug design is described that enables the structure determination of ligands complexed to virtually any biomolecular target regardless of size, composition, or oligomeric state. The method utilizes saturation transfer difference (STD) NMR spectroscopy performed on a ligand complexed to a series of target samples that have been deuterated everywhere except for specific amino acid types. In this way, the amino acid composition of the ligand-binding site can be defined, and, given the three-dimensional structure of the protein target, the three-dimensional structure of the protein-ligand complex can be determined. Unlike earlier NMR methods for solving the structures of protein-ligand complexes, no protein resonance assignments are necessary. Thus, the approach has broad potential applications--especially in cases where X-ray crystallography and traditional NMR methods have failed to produce structural data. The method is called SOS-NMR for structural information using Overhauser effects and selective labeling and is validated on two protein-ligand complexes: FKBP complexed to 2-(3'-pyridyl)-benzimidazole and MurA complexed to uridine diphosphate N-acetylglucosamine.
本文描述了一种基于核磁共振(NMR)的方法,它是传统X射线晶体学和NMR方法用于基于结构的药物设计的替代方法,能够确定与几乎任何生物分子靶点复合的配体的结构,而不论其大小、组成或寡聚状态如何。该方法利用对与一系列除特定氨基酸类型外全部氘代的靶标样品复合的配体进行饱和转移差异(STD)NMR光谱分析。通过这种方式,可以确定配体结合位点的氨基酸组成,并且在已知蛋白质靶点三维结构的情况下,可以确定蛋白质-配体复合物的三维结构。与早期用于解析蛋白质-配体复合物结构的NMR方法不同,不需要对蛋白质进行共振归属。因此,该方法具有广泛的潜在应用——特别是在X射线晶体学和传统NMR方法未能产生结构数据的情况下。该方法称为利用Overhauser效应和选择性标记获取结构信息的SOS-NMR,并在两种蛋白质-配体复合物上得到验证:与2-(3'-吡啶基)-苯并咪唑复合的FKBP和与尿苷二磷酸N-乙酰葡糖胺复合的MurA。